PPARA and metabolic dysfunction-associated steatohepatitis: Administrating NASH mice with PPAR-α agonist apparently reversed steatohepatitis [47], demonstrating that the anti-inflammatory effect of UA in our study was mediated, at least partially, by PPAR-α involved pathway.